Does AMLODIPINE\VALSARTAN Cause Mobility decreased? 35 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Mobility decreased have been filed in association with AMLODIPINE\VALSARTAN. This represents 0.8% of all adverse event reports for AMLODIPINE\VALSARTAN.
35
Reports of Mobility decreased with AMLODIPINE\VALSARTAN
0.8%
of all AMLODIPINE\VALSARTAN reports
2
Deaths
11
Hospitalizations
How Dangerous Is Mobility decreased From AMLODIPINE\VALSARTAN?
Of the 35 reports, 2 (5.7%) resulted in death, 11 (31.4%) required hospitalization, and 2 (5.7%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMLODIPINE\VALSARTAN. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does AMLODIPINE\VALSARTAN Cause?
Blood pressure increased (450)
Malaise (322)
Drug ineffective (314)
Hypertension (305)
Dizziness (283)
Diabetes mellitus (251)
Death (212)
Wrong technique in product usage process (206)
Fall (197)
Headache (197)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which AMLODIPINE\VALSARTAN Alternatives Have Lower Mobility decreased Risk?
AMLODIPINE\VALSARTAN vs AMMONIUM
AMLODIPINE\VALSARTAN vs AMNESTEEM
AMLODIPINE\VALSARTAN vs AMOXAPINE
AMLODIPINE\VALSARTAN vs AMOXICILLIN
AMLODIPINE\VALSARTAN vs AMOXICILLIN\CLARITHROMYCIN\ESOMEPRAZOLE